{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:23:54Z","timestamp":1793895834091,"version":"4.8.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004082","name":"Korean Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102408","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:42:23Z","timestamp":1759552943000},"page":"102408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy"],"prefix":"10.1016","volume":"6","author":[{"given":"Junha","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Suk","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonrak","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurim","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Been","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Och","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokhyeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euijung","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungbyn","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Woo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3146-6180","authenticated-orcid":false,"given":"Insuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102408_bib1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s11912-023-01425-1","article-title":"Immunotherapy in Head and Neck Cancer: Where Do We Stand?","volume":"25","author":"Vallianou","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.xcrm.2025.102408_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11864-023-01050-x","article-title":"Immunotherapy in HPV-Related Oropharyngeal Cancers","volume":"24","author":"Roof","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102408_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102408_bib6","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib7","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1200\/JCO.22.00332","article-title":"Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent\/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651","volume":"41","author":"Haddad","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.annonc.2022.12.008","article-title":"Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study","volume":"34","author":"Psyrri","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib9","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1158\/1078-0432.CCR-23-3249","article-title":"A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma","volume":"30","author":"Kim","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","article-title":"Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment","volume":"54","author":"Barkley","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102408_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac1042","article-title":"scHumanNet: a single-cell network analysis platform for the study of cell-type specificity of disease genes","volume":"51","author":"Cha","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib14","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","article-title":"Generalizing RNA velocity to transient cell states through dynamical modeling","volume":"38","author":"Bergen","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102408_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","article-title":"Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer","volume":"3","author":"Liu","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102408_bib16","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/1078-0432.CCR-21-2635","article-title":"Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck","volume":"28","author":"Hanna","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2025.02.026","article-title":"Distinct CD8(+) T cell dynamics associate with response to neoadjuvant cancer immunotherapies","volume":"43","author":"Li","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib19","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/annonc\/mdy226","article-title":"Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma","volume":"29","author":"Tetzlaff","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib20","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1038\/s41467-023-37353-8","article-title":"Pan-cancer classification of single cells in the tumour microenvironment","volume":"14","author":"Nofech-Mozes","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib23","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102408_bib21","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1200\/JCO.2007.15.1613","article-title":"Cancer stem cells in head and neck squamous cell cancer","volume":"26","author":"Prince","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib22","article-title":"Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102408_bib24","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","article-title":"Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma","volume":"24","author":"Auslander","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102408_bib28","doi-asserted-by":"crossref","DOI":"10.4028\/b-dOXV17","article-title":"Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.102408_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41598-019-57218-9","article-title":"Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer","volume":"10","author":"Hwang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102408_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib32","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","article-title":"Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance","volume":"29","author":"Chu","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s42003-021-02146-6","article-title":"NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data","volume":"4","author":"He","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2025.102408_bib35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008667","article-title":"Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes","volume":"12","author":"Cha","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102408_bib37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barabasi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2025.102408_bib38","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s12276-020-00528-0","article-title":"Single-cell network biology for resolving cellular heterogeneity in human diseases","volume":"52","author":"Cha","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.121","article-title":"Stress and stability: applying the Anna Karenina principle to animal microbiomes","volume":"2","author":"Zaneveld","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2025.102408_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41422-020-0355-0","article-title":"A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling","volume":"30","author":"Qian","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf4968","article-title":"Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer","volume":"8","author":"Oliveira","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2025.102408_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib43","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41590-020-0760-z","article-title":"Early precursor T cells establish and propagate T cell exhaustion in chronic infection","volume":"21","author":"Utzschneider","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102408_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102408_bib45","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1158\/0008-5472.CAN-15-0584","article-title":"Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc","volume":"75","author":"Chandran","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib46","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1038\/s41467-022-32627-z","article-title":"scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib47","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2024.02.007","article-title":"CD4(+) T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy","volume":"57","author":"Franken","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102408_bib49","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/j.cell.2021.05.027","article-title":"Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop","volume":"184","author":"Marangoni","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.csbj.2021.01.025","article-title":"Systems biology analysis identifies TNFRSF9 as a functional marker of tumor-infiltrating regulatory T-cell enabling clinical outcome prediction in lung cancer","volume":"19","author":"Cho","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2025.102408_bib51","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20020190","article-title":"Interleukin 2 signaling is required for CD4(+) regulatory T cell function","volume":"196","author":"Furtado","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2020.0237","article-title":"Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial","volume":"6","author":"Rizvi","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2025.102408_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.it.2022.01.003","article-title":"Unraveling B cell trajectories at single cell resolution","volume":"43","author":"Morgan","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2025.102408_bib54","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib55","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","article-title":"Interferon-stimulated neutrophils as a predictor of immunotherapy response","volume":"42","author":"Benguigui","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib57","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41467-022-27960-2","article-title":"Immune-related adverse events and the balancing act of immunotherapy","volume":"13","author":"Conroy","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib59","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102408_bib60","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15099","article-title":"In the light of evolution:\" keratins as exceptional tumor biomarkers","volume":"11","author":"Takan","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.xcrm.2025.102408_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102408_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102408_bib63","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-023-36790-9","article-title":"A variational algorithm to detect the clonal copy number substructure of tumors from scRNA-seq data","volume":"14","author":"De Falco","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102408_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43803","article-title":"Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq","volume":"8","author":"Kotliar","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2025.102408_bib66","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1101\/gr.080531.108","article-title":"The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes","volume":"19","author":"Pruitt","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib67","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.2147\/IJGM.S332320","article-title":"The Immune-Related Gene ELF3 is a Novel Biomarker for the Prognosis of Ovarian Cancer","volume":"14","author":"Xu","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib68","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1074\/jbc.RA118.004153","article-title":"PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-beta (TGF-beta) signaling","volume":"294","author":"Ikeno","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102408_bib69","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13046-023-02597-1","article-title":"MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition","volume":"42","author":"Hsiao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gpb.2022.08.004","article-title":"TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource","volume":"21","author":"Chen","year":"2023","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.xcrm.2025.102408_bib71","article-title":"Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities","volume":"4","author":"Liu","year":"2024","journal-title":"Cell Genom."},{"key":"10.1016\/j.xcrm.2025.102408_bib72","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000515305","article-title":"Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma","volume":"10","author":"Hsu","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.xcrm.2025.102408_bib73","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1158\/1078-0432.CCR-20-4443","article-title":"Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)","volume":"27","author":"van den Ende","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102408_bib74","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41416-021-01488-6","article-title":"Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience","volume":"125","author":"Rose","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102408_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.102408_bib76","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","article-title":"Confronting false discoveries in single-cell differential expression","volume":"12","author":"Squair","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/life12060850","article-title":"Recommendations of scRNA-seq Differential Gene Expression Analysis Based on Comprehensive Benchmarking","volume":"12","author":"Gagnon","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.xcrm.2025.102408_bib78","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41467-020-14766-3","article-title":"Trajectory-based differential expression analysis for single-cell sequencing data","volume":"11","author":"Van den Berge","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102408_bib80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"Street","year":"2018","journal-title":"BMC Genom."},{"key":"10.1016\/j.xcrm.2025.102408_bib81","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1038\/s41467-020-19894-4","article-title":"muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data","volume":"11","author":"Crowell","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102408_bib82","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib83","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","article-title":"Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy","volume":"39","author":"Krishna","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","article-title":"Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers","volume":"596","author":"Caushi","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102408_bib85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.xcrm.2025.102408_bib86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"39","author":"Bi","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib87","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13059-022-02820-w","article-title":"Biology-inspired data-driven quality control for scientific discovery in single-cell transcriptomics","volume":"23","author":"Subramanian","year":"2022","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102408_bib89","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1016\/j.cell.2023.11.026","article-title":"Automatic cell-type harmonization and integration across Human Cell Atlas datasets","volume":"186","author":"Xu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102408_bib90","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.csbj.2023.03.036","article-title":"Imputation of single-cell transcriptome data enables the reconstruction of networks predictive of breast cancer metastasis","volume":"21","author":"Cha","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2025.102408_bib91","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tig.2013.05.010","article-title":"Human housekeeping genes, revisited","volume":"29","author":"Eisenberg","year":"2013","journal-title":"Trends Genet."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:10:30Z","timestamp":1788563430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":91,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004811"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102408","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102408"}}